Lantheus Holdings (LNTH) Inventory Average (2015 - 2026)
Lantheus Holdings' (LNTH) quarterly Inventory Average came in at $63.0 million in Q1 2026, down 8.12% year-on-year from $68.6 million in Q1 2025, and down 0.55% on a QoQ basis from $63.4 million in Q4 2025.
Lantheus Holdings (LNTH) Inventory Average (2015 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has 12 years of Inventory Average data on file, last reported at $63.0 million in Q1 2026.
- On a quarterly basis, Inventory Average fell 8.12% year-over-year to $63.0 million in Q1 2026; TTM through Mar 2026 was $63.0 million, a 8.12% decrease from a year earlier, with the FY2025 full-year figure at $66.3 million, changed 0.49% from the prior year.
- Inventory Average for Q1 2026 stood at $63.0 million, down from $63.4 million in the prior quarter.
- Over the last five years, Inventory Average for LNTH reached as high as $70.7 million in Q3 2024 and fell as low as $34.1 million in Q2 2022.
- Historically, Inventory Average has averaged $55.2 million across 5 years, with a median of $62.1 million in 2025.
- Across the five-year window, Inventory Average jumped 72.34% in 2024 and decreased 12.14% in 2025, its largest moves.
- Year by year, Inventory Average stood at $35.1 million in 2022, then soared by 71.47% to $60.2 million in 2023, then gained by 15.25% to $69.4 million in 2024, then declined by 8.75% to $63.4 million in 2025, then fell by 0.55% to $63.0 million in 2026.
- Per Business Quant data, the three most recent Inventory Average figures were $63.0 million in Q1 2026, $63.4 million in Q4 2025, and $62.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 1.45 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 3.18 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 2.51 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 9.02 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 180.70 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 2.11 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 3.96 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 66.75 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 1.73 Bn |
| 10 | Lantheus Holdings | 6.72 Bn | 6.22 Bn | 230.92 Mn | 63.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 63.01 Mn |
| Dec 31, 2025 | 63.36 Mn |
| Sep 30, 2025 | 62.10 Mn |
| Jun 30, 2025 | 65.64 Mn |
| Mar 31, 2025 | 68.58 Mn |
| Dec 31, 2024 | 69.43 Mn |
| Sep 30, 2024 | 70.68 Mn |
| Jun 30, 2024 | 70.14 Mn |
| Mar 31, 2024 | 66.89 Mn |
| Dec 31, 2023 | 60.25 Mn |
| Sep 30, 2023 | 54.13 Mn |
| Jun 30, 2023 | 46.98 Mn |
| Mar 31, 2023 | 38.82 Mn |
| Dec 31, 2022 | 35.13 Mn |
| Sep 30, 2022 | 34.38 Mn |
| Jun 30, 2022 | 34.10 Mn |
| Mar 31, 2022 | 34.69 Mn |
| Dec 31, 2021 | 34.54 Mn |
| Sep 30, 2021 | 32.83 Mn |
| Jun 30, 2021 | 31.04 Mn |